Conexxence 60 mg/mL single-dose prefilled syringe Images
Generic Name: denosumab
This medication has been identified as Conexxence 60 mg/mL single-dose prefilled syringe. It is supplied by Fresenius Kabi USA, LLC.
Conexxence is used in the treatment of Osteoporosis and belongs to the drug class miscellaneous bone resorption inhibitors. Not for use in pregnancy. Conexxence 60 mg/mL single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Conexxence
- Generic Name
- denosumab
- Strength
- 60 mg/mL single-dose prefilled syringe
- Availability
- Prescription only
- Drug Class
- Miscellaneous bone resorption inhibitors
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Fresenius Kabi USA, LLC
- National Drug Code (NDC)
- 65219-0668
See also:
More about Conexxence (denosumab)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous bone resorption inhibitors
- Breastfeeding
Patient resources
Other brands
Prolia, Xgeva, Jubbonti, Wyost
Professional resources
Other brands
Prolia, Xgeva, Jubbonti, Wyost, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.